10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2014 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 13, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Cash Flows From Operating Activities: | |||
| Net Earnings | $ 2,029 | 2,580 | 2,501 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Net earnings attributable to noncontrolling interest | (25) | (17) | (541) |
| Depreciation and amortization, net | 467 | 763 | 681 |
| Deferred income taxes | (542) | (491) | (1,230) |
| Stock-based compensation | 213 | 191 | 154 |
| Impairment charges | 401 | 40 | 2,180 |
| Pension settlements and amortization | 971 | 294 | 292 |
| Proceeds from Amylin diabetes alliance | 3,570 | ||
| Gain on sale of businesses and other | (567) | (9) | (35) |
| Changes in operating assets and liabilities: | |||
| Receivables | (252) | (504) | 648 |
| Inventories | (254) | (45) | (103) |
| Accounts payable | (44) | 412 | (232) |
| Deferred income | 613 | 965 | 295 |
| Income taxes payable | 171 | 126 | (50) |
| Other | (33) | (760) | (1,189) |
| Net Cash Provided by Operating Activities | 3,148 | 3,545 | 6,941 |
| Cash Flows From Investing Activities: | |||
| Proceeds from sale and maturities of marketable securities | 4,095 | 1,815 | 4,890 |
| Purchases of marketable securities | (5,719) | (1,859) | (3,607) |
| Additions to property, plant and equipment and capitalized software | (526) | (537) | (548) |
| Business divestitures and other proceeds | 3,585 | 9 | 68 |
| Business acquisitions and other payments | (219) | (7,530) | |
| Net Cash Provided by/(Used in) Investing Activities | 1,216 | (572) | (6,727) |
| Cash Flows From Financing Activities: | |||
| Short-term debt borrowings, net | 244 | 198 | 49 |
| Proceeds from issuance of long-term debt | 1,489 | 1,950 | |
| Repayments of long-term debt | (676) | (597) | (2,108) |
| Interest rate swap contract terminations | 105 | 20 | 2 |
| Issuances of common stock | 288 | 564 | 463 |
| Repurchases of common stock | (433) | (2,403) | |
| Dividends | (2,398) | (2,309) | (2,286) |
| Net Cash Used in Financing Activities | (2,437) | (1,068) | (4,333) |
| Effect of Exchange Rates on Cash and Cash Equivalents | 58 | 25 | (1) |
| Increase/(Decrease) in Cash and Cash Equivalents | 1,985 | 1,930 | (4,120) |
| Cash and Cash Equivalents at Beginning of Year | 3,586 | 1,656 | |
| Cash and Cash Equivalents at End of Year | 5,571 | 3,586 | 1,656 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |